A new study claimed that the Covid-19 vaccine may have given rise to a condition referred to as “post-teaching syndrome” (PVS) in some people. Very low condition and its biological underpinning is known, but the study is published by the study, Yale university It was highlighted that people suffering from it demonstrated symptoms like exercise intolerance, excessive fatigue, numbness, brain fog, insomnia, synergy, tinnitus, dizziness, muscle pain, and even changes in immune systems . These symptoms develop within a day or two after vaccination and can be more severe in those days that follow and persist over time.
Since the epidemic, thousands of people around the world have claimed that Kovid -19 vaccines have damaged them for a long time despite saving millions. However, very little research has been done to analyze long -term effects, especially PVS, something that researcher, Dr. Akiko Ivasaki, a immunologist from the University of Yale, wants to change, who wants to change.
“People with PVS have dismissed and ignored because PVS is not a clinically recognized position,” D. Evasaki said.
“I believe that rigorous scientific research will lead to better diagnosis, treatment and prevention of PVS. Such research will also give better transparency and safe vaccines.”
Research Methodology
Data for study listen to Yale’s immune, symptoms and treatment experiences (Listen) Studies and studies were involved in 42 participants who reported the symptoms of PVS while 22 persons did not report any related PVS symptoms .
When they analyzed the components of the immune system, people with PVS had different -different proportion to some immune cells compared with control. Like people with long covids, people with PVS showed the recurrence of Epstein-bar virus, a virus that may be dormant in the body and associated with mononucleosis, multiple sclearosis and other conditions.
Researchers said that although more study is required to understand the prevalence of PVS, their work may have laid the foundation.
“This work is still in its early stages, and we need to validate these findings. It is something we hope that we can use for diagnosis and treatment of PV below the road. “
He may have better vaccines than the deep understanding of PVS and its drivers, which have less side effects, effective methods for diagnosis of syndrome, and target for treatment.
